Treatment of newly diagnosed B-cell origin primary CNS lymphoma with systemic R-IDARAM chemotherapy and intrathecal immunochemotherapy. [electronic resource]
Producer: 20171206Description: 25783-90 p. digitalISSN:- 1949-2553
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Central Nervous System Neoplasms -- drug therapy
- Cytarabine -- administration & dosage
- Dexamethasone -- adverse effects
- Disease-Free Survival
- Female
- Humans
- Idarubicin -- administration & dosage
- Immunotherapy -- methods
- Injections, Spinal
- Kaplan-Meier Estimate
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Pilot Projects
- Rituximab -- administration & dosage
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.